Home / News / SHL Medical / SHL launches first reusable electromechanical device – the Elexy
Press Release| September 02, 2024

SHL launches first reusable electromechanical device – the Elexy

Shl Medical Introduces Elexy Electromechanical Autoinjector
Elexy is SHL’s first electromechanical device aimed to support a wide range of drug injection profiles

SHL Medical, the pioneering leader in self-injection solutions, debuts Elexy™ – a reusable electromechanical drug delivery device solution aimed to support digital therapeutics and a wide range of specialty formulations.

As biotech and pharma partners seek greater flexibility in the choice of drug delivery solutions to navigate the complexities of the drug development process, Elexy responds to this need with its reusable power unit. The power unit seamlessly integrates with disposable drug cassettes that can accommodate both cartridges and pre-filled syringes, supporting a wide range of injection profiles from drug volume, viscosity, and injection speed.

 
Go to Elexy webpage

 

The Elexy device also features connectivity through cellular and Bluetooth® options, supporting the collection of comprehensive data related to drug, container, and device use. Designed with patient-centricity in mind, the Elexy is poised to support the future of digital therapeutics while safeguarding ease of use.

SHL’s Chief Growth Officer Markus Puusepp remarked: “The introduction of Elexy marks a significant milestone for our already expansive device portfolio, further solidifying our leading market position in the drug delivery industry. Following last year’s introduction of the Molly® Connected Cap, it’s quite clear that SHL’s agile response to market demands in innovative self-injection solutions is driving advancements in the market.”

The Elexy will be showcased at the upcoming CPHI Milan, PDA Universe, PODD®, and PDA Aseptic conferences in October. Join us at one of these conferences to learn more about Elexy and SHL’s comprehensive offerings!

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem. ​

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News

20240917 Alliance Gram External Website – 7
SHL Medical |Sep 2024

SHL Medical and Grand River Aseptic Manufacturing forge strategic partnership to offer fill finish services for RTU cartridge used in Maggie 5.0® autoinjector

SHL Medical, a world-leading solutions provider of advanced drug delivery systems such as autoinjectors, pen injectors, and innovative specialty delivery systems has announced a strategic partnership with Grand River Aseptic Manufacturing (GRAM), a highly regarded contract development and manufacturing organization (CDMO) specializing in sterile injectable biologics and scalable pharmaceutical manufacturing solutions tailored to diverse client needs.

Read More